Medicure Stock Today
| MCUJF Stock | USD 0.70 0.02 2.94% |
Performance0 of 100
| Odds Of DistressLess than 39
|
Medicure is trading at 0.7 as of the 3rd of December 2024. This is a 2.94 percent increase since the beginning of the trading day. The stock's lowest day price was 0.7. Medicure has about a 39 percent probability of financial distress in the next few years of operation and has generated negative returns over the last 90 days. Equity ratings for Medicure are calculated daily based on our scoring framework. The performance scores are derived for the period starting the 4th of September 2024 and ending today, the 3rd of December 2024. Click here to learn more.
Medicure Inc., a biopharmaceutical company, engages in the research, development, and commercialization of human therapies for the cardiovascular market in Canada and the United States. The company was incorporated in 1997 and is headquartered in Winnipeg, Canada. The company has 10.25 M outstanding shares of which 15.08 K shares are now shorted by private and institutional investors with about 1.77 days to cover all short positions. More on Medicure
Moving together with Medicure Pink Sheet
Moving against Medicure Pink Sheet
Follow Valuation Odds of Bankruptcy
Check how we calculate scores
Medicure Pink Sheet Highlights
| Founder, Chairman and CEO | Albert Friesen |
| Business Concentration | Health Care, Biotechnology, Drug Manufacturers—Specialty & Generic, Healthcare (View all Sectors) |
Medicure [MCUJF] is a Pink Sheet which is traded between brokers as part of OTC trading. The company currently falls under 'Nano-Cap' category with a current market capitalization of 9.24 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Medicure's market, we take the total number of its shares issued and multiply it by Medicure's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Medicure classifies itself under Biotechnology sector and is part of Health Care industry. The entity has 10.25 M outstanding shares of which 15.08 K shares are now shorted by private and institutional investors with about 1.77 days to cover all short positions.
Medicure has accumulated about 4.83 M in cash with 3.99 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 0.47.
Check Medicure Probability Of Bankruptcy
Ownership AllocationMedicure holds significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares.
Check Medicure Ownership Details
Medicure Risk Profiles
| Mean Deviation | 1.55 | |||
| Standard Deviation | 4.32 | |||
| Variance | 18.64 | |||
| Risk Adjusted Performance | (0.01) |
Medicure Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Medicure without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Financial Widgets Now
Financial WidgetsEasily integrated Macroaxis content with over 30 different plug-and-play financial widgets |
| All Next | Launch Module |
Other Information on Investing in Medicure Pink Sheet
Medicure financial ratios help investors to determine whether Medicure Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Medicure with respect to the benefits of owning Medicure security.